Lupus is a serious disease most often diagnosed in young women age 15 to 44. While the cause is unknown, it is a complex disease that is difficult to diagnose, treat, and defeat.
Lupus nephritis (LN) affects around 50% of Lupus patients, based on clinical and laboratory findings. The main goal of the management of LN is to avoid chronic kidney disease (CKD). Current treatment strategies remain unsatisfactory in terms of complete renal response, prevention of relapses, CKD, and progression to end-stage kidney disease.
Cell therapies are very expensive and the requirements for acceptance in clinical trials leave many unable to get the care that can improve and extend their lives.
POCare centers are processing facilities dedicated to cell and gene therapies placed in medical/research institutions with the goal to significantly enhance the accessibility of advanced cell and gene therapies by lowering the processing and delivery costs and eliminating the logistical and administrative challenges related to centralized production of such therapies.
The Butterfly Biosciences Scientific Advisory Experts is made of leading scientists, professors and researchers, dedicated to exploring cell therapies for patient health improvement.